Zai Lab Q2 and Full-Year 2024 Report Shows Sales Growth and Loss Reduction
Company

Zai Lab Q2 and Full-Year 2024 Report Shows Sales Growth and Loss Reduction

Viatris Q4 and Full-Year Results Show Greater China Growth
Company

Viatris Q4 and Full-Year Results Show Greater China Growth

SciClone Pharmaceuticals Licenses Eisai's Tasurgratinib for China
CompanyDeals

SciClone Pharmaceuticals Licenses Eisai’s Tasurgratinib for China

Fosun Pharmaceutical's XS-03 Gets NMPA Green Light for CRC Study
CompanyDrug

Fosun Pharmaceutical’s XS-03 Gets NMPA Green Light for CRC Study

Sino Biopharmaceutical and Sciwind Biosciences Partner on CPX102 Development
CompanyDeals

Sino Biopharmaceutical and Sciwind Biosciences Partner on CPX102 Development

Bayer's BlueRock Therapeutics Gets Fast Track for OpCT-001 Therapy
CompanyDrug

Bayer’s BlueRock Therapeutics Gets Fast Track for OpCT-001 Therapy

Chipscreen Biosciences' CS12088 Gets NMPA Clearance for Hepatitis B Study
CompanyDrug

Chipscreen Biosciences’ CS12088 Gets NMPA Clearance for Hepatitis B Study

Hengrui Pharmaceuticals Gets NMPA Green Light for SHR-A2009 Study
CompanyDrug

Hengrui Pharmaceuticals Gets NMPA Green Light for SHR-A2009 Study

GE Healthcare's China CEO Yihao Zhang to Retire, Will Song Named Successor
Company

GE Healthcare’s China CEO Yihao Zhang to Retire, Will Song Named Successor

Zhongsheng Pharmaceutical's RAY1225 Gets Green Light for Phase III Study
CompanyMedical Device

Zhongsheng Pharmaceutical’s RAY1225 Gets Green Light for Phase III Study

Akeso Inc. Completes Patient Enrollment for AK138D1 Phase I Study
CompanyDrug

Akeso Inc. Completes Patient Enrollment for AK138D1 Phase I Study

CARsgen Therapeutics Administers KJ-C2219 in SLE Patient in IIT
CompanyDrug

CARsgen Therapeutics Administers KJ-C2219 in SLE Patient in IIT